Применение концентратов протромбинового комплекса при внутримозговом кровоизлиянии


С. Поли, Ф. Хартиг, М.Г. Селим, К.А. Молина, Д. Довлатшаи

Department of Neurology & Stroke, and Hertie Institute for Clinical Brain Research, University of Tübingen, Germany; Stroke Division, Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA; Vall d´Hebron Stroke Unit, Hospital Universitari Vall d´Hebron, Barcelona, Spain; Ottawa Hospital Research Institute and University of Ottawa, Ontario, Canada.

Литература


  1. Flibotte J.J., Hagan N., O’Donnell J., Greenberg S.M., Rosand J. Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology. 2004;63:1059–1064.
  2. Leissinger C.A., Blatt P.M., Hoots W.K., Ewenstein B. Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature. Am J Hematol. 2008;83:137–143. doi:10.1002/ajh.21046.
  3. Steiner T., Poli S., Griebe M., Hüsing J., Hajda J., Freiberger A., et al. Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial. Lancet Neurol. 2016;15:566–573. doi: 10.1016/S1474-4422(16)00110-1.
  4. Kuramatsu J.B., Gerner S.T., Schellinger P.D., Glahn J., Endres M., Sobesky J., et al. Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage. JAMA. 2015;313:824–836. doi: 10.1001/jama.2015.0846.
  5. Hemphill J.C. III, Greenberg S.M., Anderson C.S., Becker K., BendokNB.R., Cushman M., et al; American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46:2032–2060. doi: 10.1161/STR.0000000000000069.
  6. Skolnick B.E., Mathews D.R., Khutoryansky N.M., Pusateri A.E., Carr M.E. Exploratory study on the reversal of warfarin with rFVIIa in healthy subjects. Blood. 2010;116:693–701. doi: 10.1182/blood-2009-11-253492.
  7. Cucchiara B., Messe S., Sansing L., Kasner S., Lyden P.; CHANT Investigators. Hematoma growth in oral anticoagulant related intracerebral hemorrhage. Stroke. 2008;39:2993–2996. doi: 10.1161/STROKEAHA.108.520668.
  8. Dowlatshahi D., Butcher K.S., Asdaghi N., Nahirniak S., Bernbaum M.L., Giulivi A., et al; Canadian PCC Registry (CanPro) Investigators. Poor prognosis in warfarin-associated intracranial hemorrhage despite anticoagulation reversal. Stroke. 2012;43:1812–1817. doi: 10.1161/STROKEAHA.112.652065.
  9. Jüttler E., Unterberg A., Woitzik J., Bösel J., Amiri H., Sakowitz O.W., et al; DESTINY II Investigators. Hemicraniectomy in older patients with extensive middle-cerebral-artery stroke. N Engl J Med. 2014;370:1091–1100. doi: 10.1056/NEJMoa1311367.
  10. Hanley D.F., Lane K., McBee N., Ziai W., Tuhrim S., Lees K.R., et al; CLEAR III Investigators. Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial. Lancet. 2017;389:603–611. doi: 10.1016/S0140-6736(16)32410-2.


Похожие статьи


Бионика Медиа